This inventor holds 21 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Agios Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, Vertex Pharmaceuticals, Inc.. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- North Brunswick, NJ (US) (2010)
- Weban, MA (US) (2014)
- Waban, MA (US) (2010 - 2023)
Company Filing History:
6 out of 99 
6 out of 24 
5 out of 1,168 
Years Active: 2010-2026
Areas of Expertise:
Title: The Innovative Contributions of Chong-Hui Gu in Pharmaceutical Development
Introduction: Chong-Hui Gu, a prominent inventor based in Waban, MA, has made significant strides in the pharmaceutical sector, holding a total of 19 patents. His innovative work primarily focuses on drug formulations and compositions that enhance the efficacy and stability of pharmaceutical products.
Latest Patents: Among the latest patents attributed to Chong-Hui Gu are the formulations of ivosidenib, which include various polymorphs, known impurities, and stable compositions. These advancements are critical in ensuring the effectiveness of the drug in treating specific conditions. Additionally, Gu's patent titled "Pharmaceutical Composition and Administrations Thereof" describes the solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, outlining methods for manufacturing and processing these solid dispersions into various forms, including powders, granules, and mini-tablets. His contributions are particularly valuable for treating cystic fibrosis.
Career Highlights: Chong-Hui Gu has had an impactful career working with leading biotechnology companies. He has been associated with Agios Pharmaceuticals, Inc., where he has contributed to groundbreaking research and development projects. Additionally, his tenure at Vertex Pharmaceuticals, Inc. has allowed him to further refine his skills in formulation science and pharmaceutical innovations.
Collaborations: Throughout his career, Gu has collaborated with notable professionals in the industry, including Eleni Dokou and Shahla Jamzad. These collaborations have facilitated the exchange of ideas and fostered innovative solutions within the pharmaceutical realm.
Conclusion: Chong-Hui Gu's impressive portfolio of patents and his work with esteemed pharmaceutical companies reflect his commitment to innovation in drug development. His contributions not only enhance the stability and efficacy of drugs but also pave the way for new treatment approaches for various diseases. Through his continued efforts, Gu remains a key figure in the advancement of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile